PharmaTher Holdings Ltd.
PHRRF
$0.06
-$0.01-10.93%
OTC PK
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -16.17% | -21.49% | -28.91% | 38.40% | -14.19% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -48.00% | -39.02% | -0.51% | 32.20% | -20.66% |
| Operating Income | 48.00% | 39.02% | 0.51% | -32.20% | 20.66% |
| Income Before Tax | 99.34% | 33.41% | -15.35% | -9.86% | 4.37% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 99.34% | 33.41% | -15.35% | -9.86% | 4.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 99.34% | 33.41% | -15.35% | -9.86% | 4.37% |
| EBIT | 48.00% | 39.02% | 0.51% | -32.20% | 20.66% |
| EBITDA | -- | -- | -- | -32.17% | 20.69% |
| EPS Basic | 100.00% | 33.33% | -12.90% | -10.00% | 6.45% |
| Normalized Basic EPS | 100.00% | 35.29% | -6.25% | -42.11% | 14.29% |
| EPS Diluted | 100.00% | 33.33% | -12.90% | -10.00% | 6.45% |
| Normalized Diluted EPS | 100.00% | 35.29% | -6.25% | -42.11% | 14.29% |
| Average Basic Shares Outstanding | 2.82% | 3.23% | 2.71% | 0.14% | 0.40% |
| Average Diluted Shares Outstanding | 2.82% | 3.23% | 2.71% | 0.14% | 0.40% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |